Cavitation events seeded by microbubbles have been previously reported to be associated with MR-or fluorescent-contrast enhancement after focused ultrasound (FUS)-induced blood-brain barrier (BBB) opening. However, it is still unknown whether bubble activity can be correlated with the reversibility (the duration of opening and the likelihood of safe reinstatement) and the permeability of opened BBB, which is critical for the clinical translation of using passive cavitation detection to monitor, predict and control the opening. In this study, the dependence of acoustic cavitation on the BBB opening duration, permeability coefficient and histological damage occurrence were thus investigated. Transcranial pulsed FUS at 1.5 MHz in the presence of systemically circulating microbubbles was applied in the mouse hippocampi (n = 60). The stable and inertial cavitation activities were monitored during sonication. Contrast-enhanced MRI was performed immediately after sonication and every 24 h up to 6 d thereafter, to assess BBB opening, brain tissue permeability and potential edema. Histological evaluations were used to assess the occurrence of neurovascular damages. It was found that stable cavitation was well correlated with: (1) the duration of the BBB opening (r 2 = 0.77); (2) the permeability of the opened BBB (r 2 = 0.82); (3) the likelihood of safe opening (P < 0.05, safe opening compared to cases of damage; P < 0.0001, no opening compared to safe opening). The inertial cavitation dose was correlated with the resulting BBB permeability (r 2 = 0.72). to be more reliable than inertial cavitation at assessing the BBB opening within the pressure range used in this study. This study demonstrates that the stable cavitation response during BBB opening holds promise for predicting and controlling the restoration and pharmacokinetics of FUS-opened BBB. The stable cavitation response therefore showed great promise in predicting the BBB opening duration, enabling thus control of opening according to the drug circulation time. In addition, avoiding adverse effects in the brain and assessing the pharmacokinetics of the compounds delivered can also be achieved by monitoring and controlling the stable cavitation emissions.
Introduction
Focused ultrasound (FUS) with systemically administered microbubbles has been shown to transiently induce localized and reversible blood-brain barrier (BBB) opening for drug delivery to the brain McDannold 2001, Burgess and Hynynen 2013) . BBB prevents permeation of molecules greater than 400 Da from the vasculature to the brain parenchyma, rendering many potent drugs ineffective (Pardridge 2005) . Induced by FUS, oscillating microbubbles enhance local mechanical effects to the targeted vasculature, facilitating the transient opening of the BBB in the regions of interest (Aryal et al 2014) and the improvements of other brain drug delivery paradigms , Wang et al 2014b . Several therapeutic agents have thus been successfully delivered including antibodies (Kinoshita et al 2006 , Raymond et al 2008 , chemotherapeutic agents (Liu et al 2010 , Park et al 2012 , Treat et al 2012 , viral vectors (Thévenot et al 2012 , Hsu et al 2013 , and neurotrophic factors (Wang et al 2012 .
One key element to be established prior to clinical translation is to develop a real-time feedback indicator to control and predict the physiological changes after BBB opening. Contrastenhanced MRI has been employed to detect the opening (Hynynen and McDannold 2001 , Tung et al 2011a , assess any potential damage (Tung et al 2011b , map the permeability , Park et al 2012 and monitor BBB closing (Samiotaki et al 2012) . However, MRI-based evaluation of these physiological parameters, especially the reversibility and permeability, cannot be implemented with high temporal efficiency.
On the other hand, it has been well accepted that the microbubble cavitation activity plays a critical role in FUS-induced BBB opening (Tung et al 2011b) . Stable volumetric microbubble oscillation (stable cavitation) and/or transient bubble collapse (inertial cavitation) due to associated oscillations have been previously investigated , 2011a , 2011b . Transcranial passive cavitation detection (PCD) serves as a powerful tool in detecting microbubble activity in real time by characterizing their strength, mode and location through the scattering signature (Arvanitis et al 2013) .
The feasibility of correlating acoustic cavitation emissions with BBB opening assessments has previously been reported , Tung et al 2011b , Fan et al 2014 . Harmonic and ultraharmonic (O'Reilly and Hynynen 2012) emissions have been proposed as indicator candidates of opening outcomes. However, most of the previous studies used MRI contrast techniques (Tung et al 2011b to assess the opening volume. The reversibility and permeability of the opened BBB may be more vital in clinical applications. The reversibility was depicted by the duration of BBB opening and the likelihood of safe opening. Predicting and controlling the reversibility (the duration of opening and the likelihood of safe reinstatement) are important because (1) the duration of the BBB opening is critical for drug delivery because different drugs have distinct circulation times; (2) developing a real-time indicator to assess the likelihood of safe opening during FUS exposure is vital for to minimize collateral damage. The permeability coefficient K trans represents the pharmacokinetics of the MR tracer through the opened BBB, and it was shown to be associated with BBB opening volume and closing timelines (Vlachos et al 2011 , Samiotaki et al 2012 . This coefficient was also found to be correlated with the payload of a chemotherapy agent (doxorubixin) (Park et al 2012) , indicating that the K trans has the potential to indicate drug delivery to the brain after BBB opening.
In the current study, we investigate the role of acoustic cavitation in the restoration and pharmacokinetics of FUS-opened BBB, aiming at evaluating the cavitation monitoring in its assessments of the permeability, duration, and safety of BBB opening. Microbubble activity in response to ultrasound are dependent upon their initial dimensions and acoustic pressures (Ferrara et al 2007 , Qin et al 2009 , Tung et al 2011b . Here, monodisperse microbubbles with three different diameter ranges (1-2, 4-5, and 6-8 μm) in acoustic fields at different pressure amplitudes were thus used to induce variant cavitation activities. Cavitation activity was monitored during FUS treatment and quantitatively correlated with the time for BBB to close, the permeability coefficient and the histological damage occurrence.
Materials and methods

Animals
All animal studies presented herein were approved by the Columbia University Institutional Animal Care and Use Committee. A total of 60 male mice (Weight: 24.21 ± 1.72 g; C57BL/6, Harlan Laboratories, Indianapolis, IN) were anesthetized with a mixture of oxygen (0.8 L min −1 at 1.0 bar, 21 °C) and 1.5-2.0% vaporized isoflurane (SurgiVet, Smiths Medical PM, Dublin, OH) during treatment. The fur on the scalp was removed by an electric trimmer and depilatory cream in order to minimize acoustic impedance mismatch.
Microbubble preparation
Lipid-shelled monodisperse microbubbles with three different diameter ranges (1-2, 4-5, and 6-8 μm) were prepared in-house and size-isolated using the differential centrifugation method according to a previously published protocol (Feshitan et al 2009) . A Multisizer III particle counter (Beckman Coulter, Opa Locka, FL) with a 30 μm aperture was used to measure the size distribution and concentration. The concentration of microbubble solution was diluted using phosphate-buffered saline (PBS) to 8 × 10 8 numbers ml −1 prior to intravenous administration through the tail vein.
FUS
A single-element, spherical-segment FUS transducer (center frequency: 1.5 MHz; focal length: 60 mm, diameter: 60 mm; Imasonic SAS, Voray-sur-l'Ognon, France) was driven by a function generator (33220A, Agilent, Palo Alto, CA). A 50 dB power amplifier (325LA, Electronic Navigation Industries, Rochester, NY) was used to amplify the transmitted waves.
Microbubbles in the systematic circulation interacted with the transmitted ultrasound, and the re-radiated waves from microbubbles were received by a single-element FUS transducer (center frequency: 10 MHz; focal length: 60 mm; diameter: 22.4 mm; Olympus NDT, Waltham, MA). This cavitation detector was positioned through a central hole of the FUS transducer so that their foci overlapped. Cavitation signal acquisition was controlled by a pulser-receiver system (Olympus NDT, Waltham, MA) that was connected to a digitizer (Gage Applied Technologies Inc., Lachine, QC, Canada).
A 5 s sonication with a pulse repetition frequency (PRF) of 5 Hz and pulse length (PL) of 100 cycles was carried out prior to microbubble administration in order to obtain an acoustic response baseline, which was used to normalize the cavitation dose quantification. Upon completion of the microbubble injection, 60 s FUS with the same PRF and PL was applied to the targeted area. The peak rarefactional pressures (PRPs) in situ were estimated according to the calibration described in our previous reports (Wang et al 2014a) . The right hippocampus was targeted following a grid-guided targeting procedure (Choi et al 2007) while the left served as the control. The FUS focus was placed 3 mm beneath the skull so that the focal region overlapped with the hippocampus (Tung et al 2011b) .
Cavitation signal acquisition and analysis
The cavitation dose was calculated based on the integrated area under the curve of temporal power variance of the cavitation signals monitored during FUS exposure. Two cavitation parameters that characterize the cavitation behaviors were calculated: stable cavitation dose (SCD) and inertial cavitation dose (ICD). The SCD was an indicator of the strength of stable oscillation. Each PCD-recorded pulse was transformed into a power spectrum using a fast Fourier transform at a sampling frequency of 50 MHz. Harmonic and ultraharmonic components were identified as the peak value within a 300 kHz bandwidth around each harmonic (n f c , n = 1, 2, 3… f c = 1.5 MHz) and a 100 kHz bandwidth around each ultraharmonic (n f c /2, n = 3, 5, 7…) frequency in the range between 4 and 12 MHz. The SCD was then quantified by integrating the amplitude of the harmonic and ultraharmonic responses over the entire sonication duration. The ICD, which represented the scale of microbubble collapsing, was quantified based on the root mean square (RMS) of the broadband emission amplitude within specific in-harmonic windows (bandwidth: 400 kHz) between 4 and 12 MHz. These RMS amplitudes were then integrated over the same duration. The net cavitation emissions from microbubbles could then be determined by subtracting the baseline measured prior to bubble administration.
It should be noted that the ultraharmonic responses may not be detected due to the high level of broadband noise, the ambient pressure (Sun et al 2012) and/or the presence of the skull. In order to ensure that the ultraharmonic signal can be distinguished from the variation of the background noise, i.e. to increase the signal-to-noise ratio (SNR), the following algorithm was used in the quantification. We first calculated the mean plus three times of the standard deviation of the signals in each in-harmonic range that was used in the ICD quantification. The calculated value was subsequently defined as the noise level of each ultraharmonic frequency bin prior to this in-harmonic range. The ultraharmonic cavitation event was considered observed only if the ultraharmonic value increased above the aforementioned noise level.
Acoustic parameters
2.5.1. Main study. In the main study, we chose 0.30-0.60 MPa FUS with microbubbles with three different size distributions to induce BBB opening based on previous reports using the same FUS experimental setup (Tung et al 2011b) .
ICD-based safety assessments.
A previous study indicated that delivering large compounds (>500 kDa) would be associated with the detection of strong inertial cavitation. In order to test the ICD-based safety assessments, we added two more groups with higher-pressure exposures (0.75 and 0.90 MPa) using 4-5 μm microbubbles to induce more inertial cavitation events.
MRI
All MR scans were performed using a 9.4 T MR system (DRX400, Bruker Medical, Billerica, MA). After each sonication and allowing 15 min for animal transport, each mouse was placed inside the vertical bore, while being anesthetized at 30-40 breaths min −1 with isoflurane gas (1%-2%). Pre-contrast T2 weighted, Dynamic contrast-enhanced MRI (DCE-MRI) and T1-weighted MR sequences were acquired on Day 0 and every 24 h up to 6 d. T2-weighted MRI was performed to detect edema using T2-RARE sequence (TR/TE: 3300/10.9 ms, spatial resolution: 86 × 86 μm 2 , slice thickness: 500 μm). DCE-MRI was performed using a 2D FLASH T1-weighted sequence (TR/TE = 230/2.9 ms, spatial resolution: 130 × 130 μm 2 , slice thickness: 600 μm). During the third acquisition of the dynamic sequence, the animal was injected with a 0.30 mL bolus of gadodiamide (Omniscan, GE Healthcare, Princeton, NJ) intraperitoneally (IP) as described elsewhere . A T1-weighted 2D FLASH acquisition sequence (TR/TE: 230/3.3 ms, spatial resolution: 100 × 100 μm 2 , slice thickness: 400 μm) was acquired 40 min after IP administration of gadodiamide.
The volume of opening/edema and permeability were analyzed following the approaches reported by our group (Samiotaki et al 2012 , Samiotaki and Konofagou 2013 , Wang et al 2014a . Briefly, the volume of opening was quantified with volumetric measurements of hyper-intense voxels in post-contrast T1-weighted MR images. Similarly, edema volume was calculated based on hyper-intense voxels in pre-contrast T2-weighted MR images. The permeability was assessed using the general kinetic model (GKM) on the basis of DCE-MR images . The arterial input function in GKM was determined by averaging the gadodiamide concentration changes in the internal carotid artery from the entire cohort of wild-type mice. K trans , the tracer transfer rate from blood plasma to extracellular extravascular space, served as the quantitative indicator of permeability.
Histology
All mice were euthanized and transcardially perfused with 30 mL PBS followed by 60 mL 4% paraformaldehyde on Day 7. The heads were harvested and then soaked in paraformaldehyde for 24 h, followed by skull removal and fixation again in 4% paraformaldehyde for 6 d. The brains were paraffin embedded and sectioned at 6 µm in thickness. Hematoxylin and eosin (H&E) staining was performed for histological analysis. For each brain, there were 32 sections prepared, with 180 μm spacing between planes.
Statistical analysis
An unpaired two-tailed Student's t-test was performed to compare the permeability coefficients between the treated and the sham group on each day. The cavitation dependence on the likelihood of no opening, safe opening or opening with damage was examined using one-way ANOVA, followed by a post-hoc Tukey's honest significant difference test. Error bars in this study represent standard deviations and values of P < 0.05 were considered significant. The BBB was considered 'closed' when the opening volume fell below mean + three times of standard deviations of the sham group for each day. All statistical analyses were performed using GraphPad Prism 6 (La Jolla, CA).
Results
BBB opening
The opening volume and permeability of the BBB were assessed using MRI, as shown in figure 1. 3D T1-weighted MRI confirmed the opening and the corresponding K trans maps provided the pharmacokinetic evaluations of different ultrasound parameters. BBB opening were induced by 0.30-0.60 MPa FUS with monodispersed microbubbles within three different diameter ranges (table 1). As shown in figure 1 and table 1, opening volumes and K trans coefficients were augmented as the FUS pressure and microbubble size increased. The bubble size effects were evident (table 1). Three opening outcomes listed in table 1 using 1-2 μm microbubbles were found to be dramatically different from those of larger bubbles. Interestingly, the opening can be reinstated within a specific BBB opening duration in the groups of '0.60 MPa, 1-2 μm' and '0.30 MPa, 4-5 μm' without any significant inter-animal variability, i.e. openings in Group '0.60 MPa, 1-2 μm' all closed on Day 1 and openings in Group '0.30 MPa, 4-5 μm' all closed on Day 3. It indicated that these two parameter sets could potentially be used to control the BBB recovery time reliably. 
Cavitation dependence of time required to close
To investigate whether the cavitation dose can be a promising indicator to predict the reversibility of BBB, the temporal variation of SCD and ICD was obtained (figure 2). The SCD showed good agreement (r 2 = 0.77) with closing time, suggesting that the SCD could potentially be used in predicting reversibility. However, the ICD-based prediction was not shown as reliable (r 2 = 0.27). In addition, the duration of the opened BBB was found to be bubble-size dependent (figure 2). Smaller microbubbles (1-2 μm) induced shorter openings within 1 d, while larger bubbles (4-5 and 6-8 μm) produced longer openings up to 2-6 d. Consistent with the bubble-size effects in the opening assessments, stable cavitation activities of 1-2 μm microbubbles can be differentiated from those of larger bubbles (P < 0.0001) with a threshold level at around 50 dB ( figure 2(a) ). The ICD of 1-2 μm microbubbles were also found to be statistically different (figure 2(b); P < 0.05) compared to that of larger bubbles.
Permeability and its cavitation relevance
The permeability closing timeline was characterized both qualitatively and quantitatively in figure 3. Four mice were found to have 6 d-long openings based on T1-weighted MRI assessment on Day 6. We define those four animals as Long-term Opening (LO) cases, while others that closed within Day 1-6 are Reversible Opening (RO) cases. LO cases showed higher permeability coefficients than that of RO cases for each day of the experiment. In addition, K trans of LO was found to be significantly higher compared to that of the sham till Day 4. However, the K trans of the RO decreased to the same level as that of sham after Day 1, indicating that the 'open' state of LO lasted longer than that of RO. Interestingly, the K trans closing curves of RO and LO (figure 3) underwent different temporal variations. K trans in the LO cases reached a peak on Day 1 and then gradually declined while K trans in the RO cases decreased monotonically.
Having established the relationship between cavitation responses and reversibility of the opened BBB, we further investigated the relationship between cavitation dose and permeability coefficient. Both SCD (r 2 = 0.82) and ICD (r 2 = 0.73) were found to be linearly correlated with the K trans on the sonication day (figure 4). K trans of LO cases and their corresponding SCDs held the largest values among others.
Safety analysis
To identify edema and neurovascular damage after ultrasound exposure, we performed precontrast T2-weighted MRI and H&E histological analyses, respectively. Damage, including red blood cell extravasations and dark neurons, was found in four mice (excluding the one under off-targeting exposure), which were also the four LO cases. Figure 5 compared the opening volumes, T2 enhancements and H&E staining results of the RO and LO cases under the same FUS exposure. Contrary to the RO subjects, the BBB of the LO subjects remained open with edema on Day 5. All animals in the main study excluding the sham group were then categorized into three groups according to the H&E evaluations (figure 6). Cavitation responses among the three groups were compared using one-way ANOVA. The ANOVA showed significance and the post-hoc multi-comparison revealed the significantly different SCD (P < 0.05) compared Figure 6 . Measured (a) stable and (b) inertial cavitation doses compared across no opening, safe opening and opening with damage cases. Number of mice: 46 (excluding the sham group); *: P < .05; ***: P < .001; ****: P < .0001; ns: no significance. Error bar represents mean ± std. across 'no opening', 'safe opening' and 'opening with damage' cases. Note that the four cases with histological damage are the same cases with edema on Day 5 so that we did not differentiate the edema and histological damage. These findings indicate that the SCD may also be used as a measure of likelihood for safe opening, which further demonstrated the reliability of SCD-based prediction of opening outcomes.
Finally, in order to further investigate the ICD-based prediction of the safety assessments, we did an extensive study including two more groups with higher-pressure exposures (0.75 and 0.90 MPa) using 4-5 μm microbubbles. Figure 7 showed the cavitation comparisons across 'safe openings', 'opening with edema' and 'opening with histological damage' (Note that all the subjects were successfully opened by 0.30-0.90 MPa FUS with 4-5 μm microbubbles). These results revealed the significantly different SCD (P < 0.01) and ICD (P < 0.01) compared across safe opening, opening with edema and opening with histological damage subjects. The ICD-based prediction of safety could thus be accomplished after FUS exceeds certain pressure (i.e. stronger inertial cavitation activities are induced).
Discussion
In this study, the feasibility of assessing the restoration and pharmacokinetics of FUS-opened BBB based on monitoring cavitation signals was investigated. Our results revealed that stable cavitation signals from oscillating microbubbles can be utilized to potentially predict and control the duration of BBB opening, the likelihood of safe opening and the permeability of the opened BBB. A real-time feedback method based on monitoring SCD could then be used to control and predict the physiological changes during FUS exposure.
Cavitation dependence and mechanisms
Our results indicated that, at low to moderate pressure levels (0.30-0.60 MPa) in vivo, SCD showed good correlations with the reinstatement time, likelihood of safe opening and K trans ; while ICD was only well correlated with K trans . Possible causes may be attributed to cavitational mechanisms. Sustained stable cavitation could thus be the dominant physical mechanism in opening the BBB at low to moderate pressure levels, at which FUS exposures are normally kept to avoid damage to the brain. The inertial cavitation threshold is higher than the occurrence of sustained stable cavitation (Bader and Holland 2013) . Within the range of 0.30-0.60 MPa, stable cavitating microbubbles cause physiological effects, while only a small number of nuclei undergo inertial cavitation (Tung et al 2011b) . Stable cavitation may thus dominate the cavitation activities to induce BBB opening.
Additionally, SCD may also be used to gauge the likelihood for safe opening. This finding is in agreement with the numerical investigation by Bader et al (Bader and Holland 2013) . The threshold of inertial cavitation predicted by the Mechanical Index (MI, f PRP / c ), which is the standard indicator for adverse bio-effects, is MI = 0.4 (Holland et al 2000, Bader and Holland 2013 (Bader and Holland 2013) . The parameters used in the present study (0.30-0.60 MPa at 1.5 MHz) appeared in the range of I CAV from 0.2 to 0.4, and MI from 0.245 to 0.49, suggesting that the likelihood of stable cavitation was evident and that of the inertial cavitation was lower (i.e. smaller number of nuclei would undergo inertial cavitation).
Pharmacodynamic evaluations
The good correlation between cavitation responses with BBB permeability (figure 4) indicated that monitoring cavitation activities would aid in monitoring the pharmacokinetics of the drugs to be delivered. Interestingly, figure 3 showed that the K trans peak in the LO cases was reached 24 h after BBB opening, whereas the permeability of RO decreased as time progressed. This may be attributed to the edema that was detected until Day 5 (figure 5). T2-weighted MR images of LO subjects indicated larger hyper-intense areas on the sonicated side on Day 1 than that on Day 0. The existence of edema may affect the contrast in DCE-MRI as well as the quantification of K trans .
Control the opening
To monitor and control the opening using real-time feedback during FUS is the ultimate goal for clinical translation. O'Reilly et al ) designed a semi-closedloop controlling system for BBB opening. They detected ultraharmonic components in the loop, and decreased the pressure to different target levels (% pressure to achieve ultraharmonics) once ultraharmonic emission detected. Target levels were found to be associated with MRI enhancement and damage occurrence. Albeit the potential of this controlling paradigm, one limitation is that the controlling relied on the successful detection of ultraharmonics, and then it became open-loop for the remainder of the sonications. However, it has been reported that ultraharmonic emissions were only occasionally observed in some PCD systems , which might affect the performance of ultraharmonic-based controller. Moreover, many other important matrixes, such as the cavitation doses of harmonics and broadband noise, had not been implemented into the feed-back control. Based on our findings, monitoring of these cavitation doses is associated with not only the direct opening assessments (such as MRI and/or fluorescence contrast enhancement), but also the other opening's characteristics (such as the opening duration, safety and permeability). To achieve the desired opening, FUS pressure, PL and/or PRF can be programmed based on the cavitation monitoring feedback. In addition, the cumulative cavitation doses may serve as the end or critical turning point of FUS exposure. For example, one can stop or decrease the level of FUS exposure once a certain amount of SCD and/or ICD has been reached. However, it should be noted that results of the present study were in agreement with O'Reilly et al's that the damage occurrence did not correlate with wideband responses well while it was associated with strong stable cavitation response. It suggested that the window to achieve safe opening was limited and we may have to be conservative in setting the parameters in the controller. For instance, one may want to avoid opening in 5 days due to the safety concern.
Prior to FUS exposure, selecting more suitable parameter sets also becomes important in tailoring the opening. In this study, cavitation activities were induced by microbubbles in FUS fields with various acoustic pressures. In order to reliably tailor the opening, we have uncovered the optimal type of bubble and FUS pulse trains. For instance, the BBB can be reinstated with 100% probability within the same amount of time when sonicated under the following parameter sets: [0.60 MPa, 1-2 μm] (closed on Day 1) and [0.30 MPa, 4-5 μm] (closed on Day 3). These two parameter sets may be used to control the BBB reversibility more reliably than other parameter sets.
Safety assessments
Typically attributed to adverse bio-effects, inertial cavitation is normally intended to be avoided by lowering FUS pressure in opening the BBB (Tung et al 2011b) and other microbubble-mediated ultrasound therapy (Bader and Holland 2013) . We have demonstrated that SCD can serve as a reliable indicator to gauge the likelihood for safe opening at a low to medium pressure range. However, previous reports have shown that inertial cavitation has been associated with the successful delivery of agents larger than 500 kDa when Definity ® is used. This finding suggests that delivering larger-size agents may require inertial cavitation when smaller bubbles are used. Our results (figure 7) indicated that ICD-based safety control could be accomplished when stronger inertial cavitation activities are induced, which would ultimately help clinicians to monitor the likelihood of safe opening during treatment using ICD.
Another interesting finding is that the cases with 'opening with edema' and cases with 'opening with histological damage' were identical under 0.60 MPa, while they did not fully coincide at 0.75 and 0.90 MPa. Three different situations were then found: (1) with edema but without histological damage; (2) without edema but with histological damage; and (3) with edema and with histological damage. The first situation can be attributed to the sensitivity of H&E histological evaluations. The second may result from physiological reinstatement of BBB. Future studies will investigate the detailed physiological mechanisms and their correlation with cavitation activities.
Limitations
There are several limitations to this study. First, MRI assessment was performed on a daily basis, so that the detection of closing is not precise in terms of hours. In other words, the time required for BBB reinstatement may be overestimated by no more than 24 h. Moreover, it should be noted that the opening findings are tied to the MR tracer used in the assessments. Based on our previous results assessed by fluorescently tagged dextrans, the position and areas of opening were agent-size relevant . Thus, MR contrast agents at different molecular weights would result in distinct reversibility and permeability outcomes. Lastly, the global cavitation matrixes (SCD and ICD) were found to be bubble-size dependent. It would be interesting to normalize the SCD and ICD by an appropriate scaling factor, such as the scattering cross section of microbubbles, so that more detailed cavitation mechanisms may be uncovered. The cross section of larger bubbles would result in more scattering, and thus more cavitation emissions (Ainslie and Leighton 2011) . Unfortunately, it is hard to calculate the scattering cross section at this time, since an elaborate simulation study will need to be performed. We will assess this effect in our future work.
Conclusion
In summary, we have shown that monitoring of the cavitation behavior during FUS can reliably predict the duration of opening, the permeability of the induced BBB opening and the likelihood of safe opening. The stable cavitation dose may therefore provide a real-time predictor of the properties of the induced reversible disruption. Finally, the dependence of the BBB reversibility on the bubble diameter and FUS pressure allows for the control of the safety profile of this technique.
